Zhesheng Zhou

发表

The Role of Membrane-Associated E3 Ubiquitin Ligases in Cancer

Li Jiang, Qiaojun He, Ji Cao, 2022, Frontiers in Pharmacology.

Structure-based rational design enables efficient discovery of a new selective and potent AKT PROTAC degrader.

Xiaowu Dong, Yizhe Wu, J. Che, 2022, European journal of medicinal chemistry.

Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor

Li Jiang, Qiaojun He, Ji Cao, 2021, European Journal of Medicinal Chemistry.